| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d16052c0a129131f3da2e1f9d77d065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87e7bafd9928f0f5b53b20a39bed770a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03f45420d5757bd9b910224765de2a52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 |
| filingDate |
2002-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2147bc1ad549880b4e777d11793b989f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca129eac96b91f7ba1e0ea73fbb05a81 |
| publicationDate |
2003-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03051388-A2 |
| titleOfInvention |
Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases |
| abstract |
The present invention relates to a novel pharmaceutical composition comprising interferon-Ϝ or pirfenidone and a diagnostic array of candidate polynucleotides for the improved treatment of lung diseases, especially for all forms of interstitial lung diseases. This invention describes the combination of molecular diagnosis and clinical therapy as a novel medication principle for reduction of mortality and improvement of disease management in interstitial lung diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010065755-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10406105-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11072787-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8425935-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004019863-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1644028-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8916152-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9657092-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004019863-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005004899-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018195338-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11767520-B2 |
| priorityDate |
2001-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |